The Investing Podcast
December 12, 2022 - Daily Market Briefing
Ben and Tom discuss Amgens talks to buy Horizon Therapeutics in a deal with north of $20 billion. Developments in Exergonic nuclear fusion show signs of being the best possible future for clean energ